Evidence map›Paper›PMID 11519843›Full record

ReviewHealth care management science2001

AIDS policy modeling for the 21st century: an overview of key issues.

M S Rauner, M L Brandeau

Abstract readReview
PubMed Publisher
In one paragraph

Review in Health care management science, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. S4HARA: System for HIV/AIDS resource allocation.Cost effectiveness and resource allocation : C/E · 2008
    Article
  4. Article
  5. Preventing HIV in injection drug users: choosing the best mix of interventions for the population.Journal of urban health : bulletin of the New York Academy of Medicine · 2003
    Article
  6. Article
  7. Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice.Medical decision making : an international journal of the Society for Medical Decision Making
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M S RaunerUniversity of Vienna, School of Business Economics and Computer Science, Institute of Business Studies, Department of Innovation and Technology Management, Austria. marion.rauner@univie.ac.at.
M L Brandeau

Funding

PUBLIC HLTH IMPACT AND COST EFFECTIVENESS OF HIV INTERVR01DA009531 · NIDA · YALE UNIVERSITY · PI THOMSEN, DONALD L · 1996 to 2000
$753k
NIDA NIH HHS R-01-DA-09531
6 · The paper itself

Abstract

Decisions about HIV prevention and treatment programs are based on factors such as program costs and health benefits, social and ethical issues, and political considerations. AIDS policy models--that is, models that evaluate the monetary and non-monetary consequences of decisions about HIV/AIDS interventions--can play a role in helping policy makers make better decisions. This paper provides an overview of the key issues related to developing useful AIDS policy models. We highlight issues of importance for researchers in the field of AIDS policy modeling as well as for policy makers. These include geographic area, setting, target groups, interventions, affordability and effectiveness of interventions, type and time horizon of policy model, and type of economic analysis. This paper is not intended to be an exhaustive review of the AIDS policy modeling literature, although many papers from the literature are discussed as examples; rather, we aim to convey the composition, achievements, and challenges of AIDS policy modeling.

Indexed as

Communicable Disease ControlHealth PlanningHealth PolicyModels, TheoreticalAcquired Immunodeficiency SyndromeCounselingGlobal HealthHealth Services AccessibilityHumansPolicy MakingTreatment OutcomeUniversal Precautions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.